Le Lézard
Classified in: Health
Subject: SVY

EHR Supplier Base in EMEA Consolidates


CRANFIELD, United Kingdom, Jan. 20, 2021 /PRNewswire/ -- The EMEA market for Electronic Healthcare Records (EHR) IT is estimated to have been worth $3.9B in 2020 (acute and ambulatory) according to Signify Research's 2021 global EMR report. However, 2020 saw several shake-ups which changed the complexion of vendor market shares across the region, namely:

The vendor market share table shows estimated revenue shares in 2019 for the acute & health system EHR market in EMEA.   

At a country/sub-regional level:

Outlook for EMEA EHR Market Competitive Environment

Although there has been a certain level of consolidation in the European market, across the region the supplier base remains relatively fragmented, with most countries still dominated by a mix of local and international vendors. While consolidation of the supplier base has been a recent theme, Cerner's decision to pull out of markets not driving its Millennium/i.s.h.med business is a sign that a broad footprint addressed via a broad portfolio does not always make the best business sense.

About the Report
"EHR/EMR in Acute and Ambulatory Applications ? World ? 2021" has been compiled by Signify Research using data from over 200 EHR vendors to create a bottoms-up view of the market.

Media contact:
Alex Green
[email protected]
+44 1234 986111

 

SOURCE Signify Research


These press releases may also interest you

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...

26 avr 2024
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: